메뉴 건너뛰기




Volumn 11, Issue 4, 2009, Pages 265-270

Antihypertensive treatment and stroke prevention: From recent meta-analyses to the PRoFESS trial

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; INDAPAMIDE PLUS PERINDOPRIL; LISINOPRIL; LOSARTAN; PERINDOPRIL; PLACEBO; RENIN; TELMISARTAN;

EID: 67651113461     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0045-2     Document Type: Review
Times cited : (6)

References (46)
  • 1
    • 0038031723 scopus 로고    scopus 로고
    • International Society of Hypertension (ISH): Statement on blood pressure lowering and stroke prevention
    • Chalmers J, Todd A, Chapman N, et al.: International Society of Hypertension (ISH): Statement on blood pressure lowering and stroke prevention. J Hypertens 2003, 21: 651-663.
    • (2003) J Hypertens , vol.21 , pp. 651-663
    • Chalmers, J.1    Todd, A.2    Chapman, N.3
  • 2
    • 23344449697 scopus 로고    scopus 로고
    • Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: Results of the ForLife study
    • Mancia G, Ambrosioni E, Rosei EA, et al.: Blood pressure control and risk of stroke in untreated and treated hypertensive patients screened from clinical practice: Results of the ForLife study. J Hypertens 2005, 23: 1575-1581.
    • (2005) J Hypertens , vol.23 , pp. 1575-1581
    • Mancia, G.1    Ambrosioni, E.2    Rosei, E.A.3
  • 3
    • 34250350040 scopus 로고    scopus 로고
    • 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
    • Mancia G, De Backer G, Dominiczak A, et al.: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25: 1105-1187.
    • (2007) J Hypertens , vol.25 , pp. 1105-1187
    • Mancia, G.1    De Backer, G.2    Dominiczak, A.3
  • 4
    • 33745956809 scopus 로고    scopus 로고
    • Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council
    • Goldstein LB, Adams R, Alberts MJ, et al.: Primary prevention of ischemic stroke: A guideline from the American Heart Association/ American Stroke Association Stroke Council. Circulation 2006, 113: e873-e923.
    • (2006) Circulation , vol.113
    • Goldstein, L.B.1    Adams, R.2    Alberts, M.J.3
  • 5
    • 0036623822 scopus 로고    scopus 로고
    • Secondary prevention of stroke: Old and new evidence
    • Mancia G, Grassi G: SecondOry prevention of stroke: old and new evidence. Aging Clin Exp Res 2002, 14: 216-220.
    • (2002) Aging Clin Exp Res , vol.14 , pp. 216-220
    • Mancia, G.1    Grassi, G.2
  • 6
    • 52249116778 scopus 로고    scopus 로고
    • Telmisartan to prevent recurrent stroke and cardiovascular events
    • for PRoFESS Study Group:
    • Yusuf S, Diener HC, Sacco RL, et al.; for PRoFESS Study Group: Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008, 359: 1225-1237.
    • (2008) N Engl J Med , vol.359 , pp. 1225-1237
    • Yusuf, S.1    Diener, H.C.2    Sacco, R.L.3
  • 7
    • 0025779484 scopus 로고
    • Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
    • Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991, 22: 983-988.
    • (1991) Stroke , vol.22 , pp. 983-988
    • Wolf, P.A.1    Abbott, R.D.2    Kannel, W.B.3
  • 8
    • 0343273397 scopus 로고
    • Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts
    • Prospective Studies Collaboration:
    • Prospective Studies Collaboration: Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995, 346: 1647-1653.
    • (1995) Lancet , vol.346 , pp. 1647-1653
  • 9
    • 0025234906 scopus 로고
    • Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
    • MacMahon S, Peto R, Cutler J, et al.: Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335: 765-774.
    • (1990) Lancet , vol.335 , pp. 765-774
    • MacMahon, S.1    Peto, R.2    Cutler, J.3
  • 10
    • 0027469656 scopus 로고
    • Blood pressure, systolic and diastolic, and cardiovascular risks. US population data
    • Stamler J, Stamler R, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993, 153: 598-615.
    • (1993) Arch Intern Med , vol.153 , pp. 598-615
    • Stamler, J.1    Stamler, R.2    Neaton, J.D.3
  • 11
    • 0028306578 scopus 로고
    • Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease
    • Collins R, MacMahon S: Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994, 50: 272-298.
    • (1994) Br Med Bull , vol.50 , pp. 272-298
    • Collins, R.1    MacMahon, S.2
  • 12
    • 0036600393 scopus 로고    scopus 로고
    • Systolic blood pressure: An underestimated cardiovascular risk factor
    • Mancia G, SeravalleAG, Grassi G: Systolic blood pressure: an underestimated cardiovascular risk factor. J Hypertens 2002, 20(Suppl 5): S21-S27.
    • (2002) J Hypertens , vol.20 , Issue.SUPPL. 5
    • Mancia, G.1    Seravalle, G.2    Grassi, G.3
  • 13
    • 0032885836 scopus 로고    scopus 로고
    • Isolated systolic hypertension: Prognostic information provided by pulse pressure
    • Domanski MJ, Davis BR, Pfeffer MA, et al.: Isolated systolic hypertension: Prognostic information provided by pulse pressure. Hypertension 1999, 34: 375-380.
    • (1999) Hypertension , vol.34 , pp. 375-380
    • Domanski, M.J.1    Davis, B.R.2    Pfeffer, M.A.3
  • 14
    • 0031683011 scopus 로고    scopus 로고
    • Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects
    • Benetos A, Rudnichi A, Safar M, Guize L: Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998, 32: 560-564.
    • (1998) Hypertension , vol.32 , pp. 560-564
    • Benetos, A.1    Rudnichi, A.2    Safar, M.3    Guize, L.4
  • 15
    • 0030745808 scopus 로고    scopus 로고
    • Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly?
    • Nielsen WB, Lindenstrom E, Vestbo J, Jensen GB: Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly? Am J Hypertens 1997, 10: 634-639.
    • (1997) Am J Hypertens , vol.10 , pp. 634-639
    • Nielsen, W.B.1    Lindenstrom, E.2    Vestbo, J.3    Jensen, G.B.4
  • 16
    • 0012666855 scopus 로고    scopus 로고
    • Aortic stiffness is an independent predictor of fatal stroke in essential hypertension
    • Laurent S, Katsahian S, Fassot C, et al.: Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003, 34: 1203-1206.
    • (2003) Stroke , vol.34 , pp. 1203-1206
    • Laurent, S.1    Katsahian, S.2    Fassot, C.3
  • 17
    • 0033613192 scopus 로고    scopus 로고
    • Association between local pulse pressure, mean blood pressure, and large-artery remodelling
    • Boutouyrie P, Bussy C, Lacolley P, et al.: Association between local pulse pressure, mean blood pressure, and large-artery remodelling. Circulation 1999, 100: 1387-1393.
    • (1999) Circulation , vol.100 , pp. 1387-1393
    • Boutouyrie, P.1    Bussy, C.2    Lacolley, P.3
  • 18
    • 0027958469 scopus 로고
    • Stroke risk profile: Adjustment for antihypertensive medication. The Framingham Study
    • D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB: Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 1994, 25: 40-43.
    • (1994) Stroke , vol.25 , pp. 40-43
    • D'Agostino, R.B.1    Wolf, P.A.2    Belanger, A.J.3    Kannel, W.B.4
  • 19
    • 0037130648 scopus 로고    scopus 로고
    • New evidence for stroke prevention: Scientific review
    • Straus SE, Majumdar SR, McAlister FA: New evidence for stroke prevention: Scientific review. JAMA 2002, 288: 1388-1395.
    • (2002) JAMA , vol.288 , pp. 1388-1395
    • Straus, S.E.1    Majumdar, S.R.2    McAlister, F.A.3
  • 20
    • 0035922695 scopus 로고    scopus 로고
    • Cardiovascular protection and blood pressure reduction: A meta-analysis
    • Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: A meta-analysis. Lancet 2001, 358: 1305-1315.
    • (2001) Lancet , vol.358 , pp. 1305-1315
    • Staessen, J.A.1    Wang, J.G.2    Thijs, L.3
  • 21
    • 0031439427 scopus 로고    scopus 로고
    • Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence
    • for the INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators:
    • Gueyffier F, Boissel JP, Boutitie F, et al., for the INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators: Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. Stroke 1997, 28: 2557-2562.
    • (1997) Stroke , vol.28 , pp. 2557-2562
    • Gueyffier, F.1    Boissel, J.P.2    Boutitie, F.3
  • 22
    • 0035968623 scopus 로고    scopus 로고
    • Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
    • PROGRESS Collaborative Group:
    • PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358: 1033-1041.
    • (2001) Lancet , vol.358 , pp. 1033-1041
  • 23
    • 0028811682 scopus 로고
    • Post-stroke antihypertensive treatment study. A preliminary result
    • PATS Collaborating Group:
    • PATS Collaborating Group: Post-stroke antihypertensive treatment study. A preliminary result. Chin Med J (Engl) 1995, 108: 710-717.
    • (1995) Chin Med J (Engl) , vol.108 , pp. 710-717
  • 24
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
    • for the Heart Outcomes Prevention Evaluation Study Investigators:
    • Yusuf S, Sleight P, Pogue J, et al., for the Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342: 145-153.
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3
  • 25
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • for the HOT Study Group:
    • Hansson L, Zanchetti A, Carruthers SG, et al., for the HOT Study Group: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998, 351: 1755-1762.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3
  • 26
    • 0033281522 scopus 로고    scopus 로고
    • Blood pressure control in type 2 diabetes-What does the United Kingdom Prospective Diabetes Study (UKPDS) tell us?
    • Bilous R: Blood pressure control in type 2 diabetes-What does the United Kingdom Prospective Diabetes Study (UKPDS) tell us? Nephrol Dial Transplant 1999, 14: 2562-2564.
    • (1999) Nephrol Dial Transplant , vol.14 , pp. 2562-2564
    • Bilous, R.1
  • 27
    • 0012391671 scopus 로고    scopus 로고
    • Treatment of hypertension and the J curve
    • Hansson L: Treatment of hypertension and the J curve. J Clin Hypertens (Greenwich) 1999, 1: 136-140.
    • (1999) J Clin Hypertens (Greenwich) , vol.1 , pp. 136-140
    • Hansson, L.1
  • 28
    • 0033528524 scopus 로고    scopus 로고
    • Antihypertensive drugs in very old people: A subgroup meta-analysis of randomised controlled trials
    • Gueyffier F, Bulpitt C, Boissel JP, et al.: Antihypertensive drugs in very old people: A subgroup meta-analysis of randomised controlled trials. Lancet 1999, 353: 793-796.
    • (1999) Lancet , vol.353 , pp. 793-796
    • Gueyffier, F.1    Bulpitt, C.2    Boissel, J.P.3
  • 29
    • 10744233011 scopus 로고    scopus 로고
    • Results of the pilot study for the Hypertension in the Very Elderly Trial
    • Bulpitt CJ, Beckett NS, Cooke J, et al.: Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 2003, 21: 2409-2417.
    • (2003) J Hypertens , vol.21 , pp. 2409-2417
    • Bulpitt, C.J.1    Beckett, N.S.2    Cooke, J.3
  • 30
    • 0343487983 scopus 로고    scopus 로고
    • Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
    • for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators:
    • Staessen JA, Fagard R, Thijs L, et al., for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997, 350: 757-764.
    • (1997) Lancet , vol.350 , pp. 757-764
    • Staessen, J.A.1    Fagard, R.2    Thijs, L.3
  • 31
    • 0036668188 scopus 로고    scopus 로고
    • Systolic and diastolic blood pressure control in antihypertensive drug trials
    • Mancia G, Grassi G: Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 2002, 20: 1461-1464.
    • (2002) J Hypertens , vol.20 , pp. 1461-1464
    • Mancia, G.1    Grassi, G.2
  • 32
    • 0032984862 scopus 로고    scopus 로고
    • Excess stroke among hypertensive men and women attributable to under-treatment of hypertension
    • Klungel OH, Stricker BH, Paes AH, et al.: Excess stroke among hypertensive men and women attributable to under-treatment of hypertension. Stroke 1999, 30: 1312-1318.
    • (1999) Stroke , vol.30 , pp. 1312-1318
    • Klungel, O.H.1    Stricker, B.H.2    Paes, A.H.3
  • 33
    • 0032543897 scopus 로고    scopus 로고
    • Survival in treated hypertension: Follow up study after two decades
    • Andersson OK, Almgren T, Persson B, et al.: Survival in treated hypertension: Follow up study after two decades. BMJ 1998, 317: 167-171.
    • (1998) BMJ , vol.317 , pp. 167-171
    • Andersson, O.K.1    Almgren, T.2    Persson, B.3
  • 34
    • 0041384377 scopus 로고    scopus 로고
    • Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population
    • Benetos A, Thomas F, Bean KE, Guize L: Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population. J Hypertens 2003, 21: 1635-1640.
    • (2003) J Hypertens , vol.21 , pp. 1635-1640
    • Benetos, A.1    Thomas, F.2    Bean, K.E.3    Guize, L.4
  • 35
    • 0033034404 scopus 로고    scopus 로고
    • Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
    • Hansson L, Lindholm LH, Niskanen L, et al.: Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999, 353: 611-616.
    • (1999) Lancet , vol.353 , pp. 611-616
    • Hansson, L.1    Lindholm, L.H.2    Niskanen, L.3
  • 36
    • 0344373794 scopus 로고    scopus 로고
    • The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288: 2981-2997.
    • (2002) JAMA , vol.288 , pp. 2981-2997
  • 37
    • 0037534905 scopus 로고    scopus 로고
    • The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial
    • Lithell H, Hansson L, Skoog I, et al.: The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial. J Hypertens 2003, 21: 875-886.
    • (2003) J Hypertens , vol.21 , pp. 875-886
    • Lithell, H.1    Hansson, L.2    Skoog, I.3
  • 38
    • 0037160968 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
    • Dahlof B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 2002, 359: 995-1003.
    • (2002) Lancet , vol.359 , pp. 995-1003
    • Dahlof, B.1    Devereux, R.B.2    Kjeldsen, S.E.3
  • 39
    • 52149090673 scopus 로고    scopus 로고
    • Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: A meta-analysis
    • Reboldi G, Angeli F, Cavallini C, et al.: Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: A meta-analysis. J Hypertens 2008, 26: 1282-1289.
    • (2008) J Hypertens , vol.26 , pp. 1282-1289
    • Reboldi, G.1    Angeli, F.2    Cavallini, C.3
  • 40
    • 0030902115 scopus 로고    scopus 로고
    • Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
    • Pitt B, Segal R, Martinez FA, et al.: Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997, 349: 747-752.
    • (1997) Lancet , vol.349 , pp. 747-752
    • Pitt, B.1    Segal, R.2    Martinez, F.A.3
  • 41
    • 0034612118 scopus 로고    scopus 로고
    • Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II
    • Pitt B, Poole-Wilson PA, Segal R, et al.: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - he Losartan Heart Failure Survival Study ELITE II. Lancet 2000, 355: 1582-1587.
    • (2000) Lancet , vol.355 , pp. 1582-1587
    • Pitt, B.1    Poole-Wilson, P.A.2    Segal, R.3
  • 42
    • 7444237666 scopus 로고    scopus 로고
    • Diabetics Exposed to Telmisartan and Enalapril Study Group: Angiotensinreceptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
    • Barnett AH, Bain SC, Bouter P, et al.; Diabetics Exposed to Telmisartan and Enalapril Study Group: Angiotensinreceptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med 2004, 351: 1952-1961.
    • (2004) N Engl J Med , vol.351 , pp. 1952-1961
    • Barnett, A.H.1    Bain, S.C.2    Bouter, P.3
  • 43
    • 0037036971 scopus 로고    scopus 로고
    • Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: The OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan
    • Dickstein K, Kjekshus J: Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Lancet 2002, 360: 752-760.
    • (2002) Lancet , vol.360 , pp. 752-760
    • Dickstein, K.1    Kjekshus, J.2
  • 44
    • 0242490542 scopus 로고    scopus 로고
    • Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
    • Pfeffer MA, McMurray JJ, Velazquez EJ, et al.: Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003, 349: 1893-1906.
    • (2003) N Engl J Med , vol.349 , pp. 1893-1906
    • Pfeffer, M.A.1    McMurray, J.J.2    Velazquez, E.J.3
  • 45
    • 42049107348 scopus 로고    scopus 로고
    • Telmisartan, ramipril, or both in patients at high risk for vascular events
    • Yusuf S, Teo KK, Pogue J, et al.: Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008, 358: 1547-1559.
    • (2008) N Engl J Med , vol.358 , pp. 1547-1559
    • Yusuf, S.1    Teo, K.K.2    Pogue, J.3
  • 46
    • 34147116836 scopus 로고    scopus 로고
    • Blood pressure-dependent and independent effects of agents that inhibit the rennin-angiotensin system
    • Blood Pressure Lowering Treatment Trialists' Collaboration
    • Blood Pressure Lowering Treatment Trialists' Collaboration, Turnbull F, Neal B, et al.: Blood pressure-dependent and independent effects of agents that inhibit the rennin-angiotensin system. J Hypertens 2007, 25: 951-958.
    • (2007) J Hypertens , vol.25 , pp. 951-958
    • Turnbull, F.1    Neal, B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.